Teams link: Join the meeting now

Meeting ID: 277 080 580 861 9

Passcode: nk3a6S6b

Learning Objectives: 

  • Summarize ovarian cancer as a disease state, treatment guidelines, and current medications used.

  • Summarize the essential drug information needed to safely and effectively dispense Avutometinib + Defactinib for ovarian cancer.

  • Explain Avutometinib + Defactinib background, clinical trial development, and place in therapy. 

Session date: 
11/20/2025 - 2:00pm to 3:00pm CST
Location: 
In-person and Virtually
Will be determined by room availability
600 Highland Ave
Madison, WI 53705
United States
See map: Google Maps
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
Add to calendar: 
Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Dylan Erdelt
Tiffany Parham
Joey Jimenez